Published in Arch Virol on January 01, 1987
Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J Clin Microbiol (1999) 3.35
Serotyping of adenoviruses on conjunctival scrapings by PCR and sequence analysis. J Clin Microbiol (1999) 1.66
Molecular diagnosis of human adenoviruses d and e by a phylogeny-based classification method using a partial hexon sequence. J Clin Microbiol (2004) 1.60
Novel human adenovirus causing nosocomial epidemic keratoconjunctivitis. J Clin Microbiol (2008) 1.42
Epidemic keratoconjunctivitis due to the novel hexon-chimeric-intermediate 22,37/H8 human adenovirus. J Clin Microbiol (2008) 1.07
Intermediate human adenovirus type 22/H10,19,37 as a new etiological agent of conjunctivitis. J Clin Microbiol (1991) 1.02
Adenovirus strains of subgenus D associated with nosocomial infection as new etiological agents of epidemic keratoconjunctivitis in Japan. J Clin Microbiol (1999) 0.93
Circulation of a novel pattern of infections by enteric adenovirus serotype 41 among children below 5 years of age in Kolkata, India. J Clin Microbiol (2010) 0.92
New genome types of adenovirus types 1, 3, and 5 isolated from stools of children in Brazil. J Clin Microbiol (1989) 0.83
Identification of a novel intertypic recombinant species D human adenovirus in a pediatric stem cell transplant recipient. J Clin Virol (2014) 0.81
Genetic organization, size, and complete sequence of early region 3 genes of human adenovirus type 41. J Virol (1996) 0.78
Identification of the hexon region of an adenovirus involved in a new outbreak of keratoconjunctivitis. J Clin Microbiol (2001) 0.75
Worldwide epidemiology of human adenovirus infections. Am J Epidemiol (1983) 3.45
Candidate adenoviruses 40 and 41: fastidious adenoviruses from human infant stool. J Med Virol (1983) 3.39
Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins. Virology (1984) 2.48
DNA restriction analysis of adenovirus prototypes 1 to 41. Arch Virol (1986) 2.20
Monoclonal antibodies against respiratory syncytial virus and their use for rapid detection of virus in nasopharyngeal secretions. J Clin Microbiol (1985) 1.96
Adenovirus 37: identification and characterization of a medically important new adenovirus type of subgroup D. J Med Virol (1981) 1.88
Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47). J Infect Dis (1988) 1.87
Isolation of a human pararotavirus. Virology (1983) 1.73
Detection of Mycoplasma pneumoniae in clinical samples from pediatric patients by polymerase chain reaction. J Clin Microbiol (1992) 1.70
[Adult-onset Still's disease. Differential diagnosis in recurrent pharyngitis, fever of unknown original and excessive hyperferritinemia]. Dtsch Med Wochenschr (1999) 1.42
Multiplex polymerase chain reaction for subgenus-specific detection of human adenoviruses in clinical samples. J Med Virol (1999) 1.42
Type- and group-specific polymerase chain reaction for adenovirus detection. Res Virol (1994) 1.35
Isolation and identification of enteric adenoviruses. J Med Virol (1983) 1.32
Adenoviridae: second report. Intervirology (1982) 1.26
New human adenovirus (candidate adenovirus 36), a novel member of subgroup D. Arch Virol (1980) 1.25
A one-year virological survey of acute intussusception in childhood. J Med Virol (1982) 1.24
A proposal for naming adenovirus genome types, exemplified by adenovirus type 6. J Gen Virol (1985) 1.22
Intermediate adenovirus strains of subgenus D occur in extensive variety. Med Microbiol Immunol (1989) 1.19
Sequence characterization and comparison of human adenovirus subgenus B and E hexons. Virology (1995) 1.17
Characterization of adenovirus subgenus D fiber genes. Virology (1995) 1.16
Neutralization of adenovirus infectivity and cytotoxin in various cell cultures. J Virol Methods (1981) 1.15
Determination of the size of HIV using adenovirus type 2 as an internal length marker. J Virol Methods (1994) 1.12
Restriction site mapping of adenovirus type 8 genome types. Res Virol (1991) 1.12
PCR-based detection and typing of human adenoviruses in clinical samples. Res Virol (1997) 1.11
Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus. Clin Exp Immunol (1994) 1.09
Characterization of adenovirus 15/H9 intermediate strains. Intervirology (1985) 1.09
A selective loss of somatostatin in the hippocampus of patients with temporal lobe epilepsy. Ann Neurol (1991) 1.07
Combined interaction of antiherpes substances and interferon beta on the multiplication of herpes simplex virus. Arch Virol (1982) 1.06
Detection of oncornavirus-like particles in HeLa cells. I. Fine structure and comparative morphological classification. Int J Cancer (1974) 1.04
Molecular epidemiology and restriction site mapping of adenovirus type 3 genome types. J Clin Microbiol (1989) 1.04
Molecular epidemiology and restriction site mapping of adenovirus 7 genome types. Arch Virol (1989) 1.03
Altered antroduodenal motility after cholecystectomy. Am J Surg (1994) 1.02
Sequence characterization of the adenovirus 31 fibre and comparison with serotypes of subgenera A to F. Res Virol (1996) 1.02
Enzyme-linked immunosorbent assay for acute adenovirus infection. J Virol Methods (1982) 1.01
The hexon genes of adenoviruses of subgenus C: comparison of the variable regions. Res Virol (1993) 1.01
Serologically intermediate adenovirus strains: a regular feature of group II adenoviruses. Arch Gesamte Virusforsch (1968) 1.00
Does adenovirus subtype 7a exist? Arch Virol (1976) 1.00
The structure of group II adenoviruses. J Gen Virol (1967) 1.00
Analysis of antigenically intermediate strains of subgenus B and D adenoviruses from AIDS patients. Arch Virol (1988) 0.98
Immunological and biochemical characterization of human adenoviruses from subgenus B. I. Antigenic relationships. Arch Virol (1985) 0.97
Adenovirus 3-7, an intermediate strain of subgenus B. Intervirology (1986) 0.97
Study of genetic reassortment between two human rotaviruses. Virology (1984) 0.97
Immunological adenovirus variant strains of subgenus D: comparison of the hexon and fiber sequences. Virology (1995) 0.97
Characterization of a plasmid coding for resistance to broad-spectrum cephalosporins in Salmonella typhimurium. Drugs Exp Clin Res (1989) 0.96
Chimpanzee adenoviruses are related to four subgenera of human adenoviruses. Intervirology (1989) 0.96
Detection and significance of adenoviruses in cases of sudden infant death. Virchows Arch (1996) 0.95
Hexon sequence of adenovirus type 7 and comparison with other serotypes of subgenus B. Res Virol (1996) 0.95
Survey of human rotavirus propagation as studied by electrophoresis of genomic RNA. J Infect Dis (1984) 0.95
Recombinant fibre proteins of human adenoviruses Ad9, Ad15 and Ad19: localization of the haemagglutination properties and the type-specific determinant. Res Virol (1997) 0.95
Serological characterization of human reassortant rotaviruses. J Virol (1986) 0.94
Epidemiologic and genomic study of rotavirus strains infecting young children and calves in the same rural environment. Eur J Epidemiol (1986) 0.94
[Serological relationship of group II adenoviruses]. Arch Gesamte Virusforsch (1968) 0.94
Immunological and biochemical characterization of human adenoviruses from subgenus B. II. DNA restriction analysis. Arch Virol (1985) 0.93
Persistent enteral infections with adenovirus types 1 and 2 in infants: no evidence of reinfection. Epidemiol Infect (1988) 0.93
Epidemiology of group II adenoviruses. Am J Epidemiol (1967) 0.92
IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus. J Rheumatol (2000) 0.91
Genome type analysis of 480 isolates of adenovirus types 1, 2, and 5. Arch Virol (1990) 0.91
Age and susceptibility of Swiss mice for mouse adenovirus, strain FL. Arch Virol (1980) 0.91
Immunological relationship among human adenoviruses of subgenus D. Arch Virol (1982) 0.90
Genome type analysis of adenovirus 31, a potential causative agent of infants' enteritis. Arch Virol (1989) 0.89
Serological and biochemical characteristics of intermediate adenovirus strains of subgenus D. Arch Virol (1987) 0.89
Gastroenteritis in infants, associated with a genome type of adenovirus 31 and with combined rotavirus and adenovirus 31 infection. Eur J Pediatr (1987) 0.87
Genome type analysis of adenovirus 37 isolates. J Med Virol (1988) 0.87
Adenoviridae. Intervirology (1976) 0.87
Immunological relationship among adenoviruses of humans, simians, and nonprimates as determined by the neutralization test. Intervirology (1981) 0.87
Combined chemotherapy of cutaneous herpes simplex infection of the guinea pig. J Med Virol (1983) 0.86
[Nosocomial rotavirus infections in adults]. Dtsch Med Wochenschr (1983) 0.86
[Infection rate with adenivirus 1 to 39 in infants and adults]. Immun Infekt (1985) 0.85
[The etiology of epidemic keratoconjunctivities (author's transl)]. Klin Monbl Augenheilkd (1975) 0.85
Total iron-binding capacity and serum transferrin determination under the influence of several clinical conditions. Clin Chim Acta (2000) 0.84
Cholecystokinin modulates mucosal immunoglobulin A function. Surgery (1997) 0.84
[Isolation of poliovirus in various tissue cultures]. Z Hyg Infektionskr (1964) 0.84
Indirect haemagglutination of human cytomegalovirus. Rev Eur Etud Clin Biol (1972) 0.84
Combined antiviral effect of DNA inhibitors on Herpes simplex virus multiplication. Med Microbiol Immunol (1980) 0.84
Epidemiological and clinical study and electrophoretyping survey of rotavirus acute diarrhoea in a children's infectious disease unit in Casablanca, Morocco. Ann Inst Pasteur Virol (1989) 0.84
Biological and biophysical characteristics of mouse adenovirus, strain FL. Arch Virol (1977) 0.84
Characteristics of mastadenovirus h 8, the causative agent of epidemic keratoconjunctivitis. Arch Virol (1983) 0.83
A mother-child combination analysis for ABO-Hp interaction. Humangenetik (1973) 0.83
Simplified enzyme-linked immunosorbent assay for specific antibodies to respiratory syncytial virus. J Clin Microbiol (1986) 0.83
Follow-up of subjects with isolated and persistent anti-core (anti-p24 or anti-p17) antibodies to HIV. AIDS (1988) 0.83
[Serologically intermediary adenovirus strains]. Arch Gesamte Virusforsch (1965) 0.83
Pyruvate kinase type tumor M2 plasma levels in patients afflicted with rheumatic diseases. Anticancer Res (2003) 0.82
The serological relationship of the soluble antigens of adenovirus type 19. J Gen Virol (1968) 0.82
Fast identification of adenovirus 40/41 in infants with enteritis. Eur J Clin Microbiol (1987) 0.82
Re: "the Seattle Virus Watch. VII. Observations of adenovirus infections". Am J Epidemiol (1978) 0.82
Molecular epidemiology of adenovirus type 21 in the Netherlands and the Federal Republic of Germany from 1960 to 1985. J Clin Microbiol (1986) 0.82
Structure, hemagglutinins, and subgroup position of adenovirus 20, 25, and 28. Arch Gesamte Virusforsch (1972) 0.81
Antiviral activity in sera of patients with influenza infection. Biomedicine (1978) 0.81
Interleukin-6 serum concentration in ankylosing spondylitis: a reliable predictor of disease progression in the subsequent year? Rheumatol Int (2000) 0.81